Royal Bank of Canada
TSVT

Royal Bank of Canada’s 2seventy bio TSVT Stock Holding History

Royal Bank of Canada’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,252
Closed -$17K – 7353
2025
Q1 		$17K Sell
3,252
-4,464
-58% -$14.2K ﹤0.01% 5980
2024
Q4 		$23K Buy
7,716
+3,143
+69% +$12.9K ﹤0.01% 6062
2024
Q3 		$21K Sell
4,573
-25
-0.5% -$113 ﹤0.01% 6098
2024
Q2 		$18K Buy
4,598
+3,452
+301% +$15.6K ﹤0.01% 6122
2024
Q1 		$6K Sell
1,146
-16,632
-94% -$78.2K ﹤0.01% 6408
2023
Q4 		$76K Buy
17,778
+7,425
+72% +$22.8K ﹤0.01% 5777
2023
Q3 		$40K Buy
10,353
+3,205
+45% +$21K ﹤0.01% 5898
2023
Q2 		$72K Buy
7,148
+3,123
+78% +$33.1K ﹤0.01% 5571
2023
Q1 		$40K Sell
4,025
-2,134
-35% -$24.4K ﹤0.01% 5740
2022
Q4 		$58K Buy
6,159
+1,729
+39% +$24.4K ﹤0.01% 5793
2022
Q3 		$66K Buy
4,430
+910
+26% +$13.5K ﹤0.01% 5585
2022
Q2 		$46K Sell
3,520
-1,385
-28% -$18.9K ﹤0.01% 5752
2022
Q1 		$84K Sell
4,905
-2,994
-38% -$50.8K ﹤0.01% 5776
2021
Q4 		$203K Buy
+7,899
New +$246K ﹤0.01% 5323

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's TSVT Position: Q2 2025 in Review

Royal Bank of Canada sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 3,252 shares — an estimated $17K sold.

Royal Bank of Canada first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $203K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Royal Bank of Canada reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 3,252 2seventy bio shares in Q2 2025, an estimated $17K.
  • Royal Bank of Canada first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Royal Bank of Canada's 2seventy bio position peaked at $203K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.